Tag: Hospitals and Clinics

Displaying 1 - 20 of 154 results.

Pages

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that UnitedHealth Group’s proposed $4.3 billion acquisition of DaVita Medical Group from DaVita, Inc. will likely harm competition in healthcare markets in Clark and Nye Counties, Nevada.
Following the decision last week of Sanford Health to abandon its proposed acquisition of Mid Dakota Clinic, the Federal Trade Commission has dismissed its case challenging the transaction through the Commission’s administrative trial process.FTC Chairman Joseph J. Simons issued the following...
Healthcare provider and insurer UnitedHealth Group Incorporated and healthcare provider DaVita, Inc. have agreed to a settlement to resolve Federal Trade Commission allegations that UnitedHealth Group’s proposed $4.3 billion acquisition of DaVita’s DaVita Medical Group will harm competition in...
The Federal Trade Commission has imposed conditions on UnitedHealth Group’s proposed acquisition of DaVita Medical Group. In its complaint, the FTC alleged that the proposed $4.3 billion acquisition would harm competition in healthcare markets in two Nevada counties, Clark and Nye....
WHAT:The Federal Trade Commission will host a workshop titled A Health Check on COPAs. FTC Chairman Joseph J. Simons will give the opening address.WHEN:Tuesday June 18, 9 a.m.-5 p.m.
The Federal Trade Commission has announced an agenda for its upcoming workshop in Washington, DC regarding the impact of certificates of public advantage, also known as COPAs, on prices, quality, access, and innovation for healthcare services.
On June 18, 2019, the Federal Trade Commission will hold a public workshop in Washington, DC to assess the impact of certificates of public advantage (“COPAs”) on prices, quality, access, and innovation for healthcare services.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Fresenius Medical Care AG’s proposed $2 billion acquisition of NxStage Medical, Inc. likely would be anticompetitive.
On June 18, 2019, the Federal Trade Commission hosted a public workshop to assess the impact of certificates of public advantage (“COPAs”) on prices, quality, access, and innovation for healthcare services. This workshop is part of a broader COPA Assessment Project announced in...
The Federal Trade Commission will require healthcare companies Fresenius Medical Care AG & KGaA (Fresenius) and NxStage Medical, Inc. (NxStage) to divest all rights and assets related to NxStage’s bloodline tubing set business to B. Braun Medical, Inc. (B. Braun) as part of a settlement...

Pages